Previous Close | 40.57 |
Open | 40.76 |
Bid | 40.08 x 1400 |
Ask | 41.19 x 900 |
Day's Range | 40.08 - 41.34 |
52 Week Range | 38.20 - 58.83 |
Volume | 1,088,177 |
Avg. Volume | 1,422,273 |
Market Cap | 5.462B |
Beta (5Y Monthly) | 1.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.20 |
Earnings Date | Apr 28, 2021 - May 03, 2021 |
Forward Dividend & Yield | 0.96 (2.34%) |
Ex-Dividend Date | Mar 11, 2021 |
1y Target Est | 56.00 |
In this article we are going to estimate the intrinsic value of Perrigo Company plc ( NYSE:PRGO ) by estimating the...
Joining today's call are President and CEO, Murray Kessler; and CFO, Ray Silcock. Please refer to the important information for shareholders and investors and safe harbor language regarding these statements in our press releases issued earlier this morning.
Perrigo agreed to sell its generic-drug business. CEO Murray Kessler says the company is "reborn again," and will focus on consumer self-care products.